-
Something wrong with this record ?
Collateral sensitivity associated with antibiotic resistance plasmids
C. Herencias, J. Rodríguez-Beltrán, R. León-Sampedro, A. Alonso-Del Valle, J. Palkovičová, R. Cantón, Á. San Millán
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2012
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2012-01-01
Open Access Digital Library
from 2013-01-01
Health & Medicine (ProQuest)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2012
PubMed
33470194
DOI
10.7554/elife.65130
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Escherichia coli drug effects genetics MeSH
- Carbapenems pharmacology MeSH
- Drug Collateral Sensitivity * MeSH
- Drug Resistance, Multiple, Bacterial genetics MeSH
- Plasmids drug effects physiology MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Collateral sensitivity (CS) is a promising alternative approach to counteract the rising problem of antibiotic resistance (ABR). CS occurs when the acquisition of resistance to one antibiotic produces increased susceptibility to a second antibiotic. Recent studies have focused on CS strategies designed against ABR mediated by chromosomal mutations. However, one of the main drivers of ABR in clinically relevant bacteria is the horizontal transfer of ABR genes mediated by plasmids. Here, we report the first analysis of CS associated with the acquisition of complete ABR plasmids, including the clinically important carbapenem-resistance conjugative plasmid pOXA-48. In addition, we describe the conservation of CS in clinical E. coli isolates and its application to selectively kill plasmid-carrying bacteria. Our results provide new insights that establish the basis for developing CS-informed treatment strategies to combat plasmid-mediated ABR.
Centro Nacional de Biotecnología CSIC Madrid Spain
Red Española de Investigación en Patología Infecciosa Instituto de Salud Carlos 3 Madrid Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012537
- 003
- CZ-PrNML
- 005
- 20220506131325.0
- 007
- ta
- 008
- 220425s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.7554/eLife.65130 $2 doi
- 035 __
- $a (PubMed)33470194
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Herencias, Cristina $u Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain $1 https://orcid.org/0000000213843109
- 245 10
- $a Collateral sensitivity associated with antibiotic resistance plasmids / $c C. Herencias, J. Rodríguez-Beltrán, R. León-Sampedro, A. Alonso-Del Valle, J. Palkovičová, R. Cantón, Á. San Millán
- 520 9_
- $a Collateral sensitivity (CS) is a promising alternative approach to counteract the rising problem of antibiotic resistance (ABR). CS occurs when the acquisition of resistance to one antibiotic produces increased susceptibility to a second antibiotic. Recent studies have focused on CS strategies designed against ABR mediated by chromosomal mutations. However, one of the main drivers of ABR in clinically relevant bacteria is the horizontal transfer of ABR genes mediated by plasmids. Here, we report the first analysis of CS associated with the acquisition of complete ABR plasmids, including the clinically important carbapenem-resistance conjugative plasmid pOXA-48. In addition, we describe the conservation of CS in clinical E. coli isolates and its application to selectively kill plasmid-carrying bacteria. Our results provide new insights that establish the basis for developing CS-informed treatment strategies to combat plasmid-mediated ABR.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a karbapenemy $x farmakologie $7 D015780
- 650 12
- $a kolaterální senzitivita $7 D000081164
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x genetika $7 D024901
- 650 _2
- $a Escherichia coli $x účinky léků $x genetika $7 D004926
- 650 _2
- $a plazmidy $x účinky léků $x fyziologie $7 D010957
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rodríguez-Beltrán, Jerónimo $u Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain $u Centro de Investigación Biológica en Red Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain $1 https://orcid.org/0000000330141229
- 700 1_
- $a León-Sampedro, Ricardo $u Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain $u Centro de Investigación Biológica en Red Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain $1 https://orcid.org/0000000153178310
- 700 1_
- $a Alonso-Del Valle, Aida $u Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain $1 https://orcid.org/0000000251545778
- 700 1_
- $a Palkovičová, Jana $u Department of Biology and Wildlife Diseases, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic $1 https://orcid.org/0000000348365239
- 700 1_
- $a Cantón, Rafael $u Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain $u Red Española de Investigación en Patología Infecciosa. Instituto de Salud Carlos III, Madrid, Spain $1 https://orcid.org/0000000316753173
- 700 1_
- $a San Millán, Álvaro $u Servicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain $u Centro de Investigación Biológica en Red Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain $u Centro Nacional de Biotecnología-CSIC, Madrid, Spain $1 https://orcid.org/0000000185440387
- 773 0_
- $w MED00188753 $t eLife $x 2050-084X $g Roč. 10, č. - (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33470194 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131317 $b ABA008
- 999 __
- $a ok $b bmc $g 1789936 $s 1163738
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 10 $c - $e 20210120 $i 2050-084X $m eLife $n eLife $x MED00188753
- LZP __
- $a Pubmed-20220425